Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.524, 2007-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Linezolid best value option for VAP in Spain
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. :
Access to resources
Recommend
Linezolid: Lack of efficacy in MRSA bacteraemia: case report
Reactions Weekly, Vol. 1, Iss. 1227, 2008-01 ,pp. :
Oral linezolid cost saving in MRSA-related infections
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. :
Daptomycin and vancomycin of similar value in MRSA infection
Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. :
Daptomycin and vancomycin of similar value in MRSA infection
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 542, 2007-01 ,pp. :